Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $7.06 billion. The enterprise value is $6.45 billion.
| Market Cap | 7.06B |
| Enterprise Value | 6.45B |
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 64.31 million shares outstanding. The number of shares has decreased by -1.26% in one year.
| Current Share Class | 64.31M |
| Shares Outstanding | 64.31M |
| Shares Change (YoY) | -1.26% |
| Shares Change (QoQ) | +10.09% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 106.80% |
| Float | 52.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 31.86 |
| PS Ratio | 95.30 |
| Forward PS | 14.63 |
| PB Ratio | 10.36 |
| P/TBV Ratio | 10.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 87.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.76 |
| Quick Ratio | 17.51 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.06% and return on invested capital (ROIC) is -162.70%.
| Return on Equity (ROE) | -17.06% |
| Return on Assets (ROA) | -12.37% |
| Return on Invested Capital (ROIC) | -162.70% |
| Return on Capital Employed (ROCE) | -21.49% |
| Weighted Average Cost of Capital (WACC) | 14.30% |
| Revenue Per Employee | $565,366 |
| Profits Per Employee | -$875,656 |
| Employee Count | 131 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -664,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.98% in the last 52 weeks. The beta is 1.83, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +94.98% |
| 50-Day Moving Average | 101.49 |
| 200-Day Moving Average | 86.18 |
| Relative Strength Index (RSI) | 61.72 |
| Average Volume (20 Days) | 563,600 |
Short Selling Information
The latest short interest is 7.29 million, so 11.34% of the outstanding shares have been sold short.
| Short Interest | 7.29M |
| Short Previous Month | 7.54M |
| Short % of Shares Out | 11.34% |
| Short % of Float | 13.89% |
| Short Ratio (days to cover) | 11.83 |
Income Statement
In the last 12 months, PTGX had revenue of $74.06 million and -$114.71 million in losses. Loss per share was -$1.79.
| Revenue | 74.06M |
| Gross Profit | 74.06M |
| Operating Income | -142.47M |
| Pretax Income | -115.38M |
| Net Income | -114.71M |
| EBITDA | -141.02M |
| EBIT | -142.47M |
| Loss Per Share | -$1.79 |
Balance Sheet
The company has $547.79 million in cash and $9.78 million in debt, with a net cash position of $610.56 million or $9.49 per share.
| Cash & Cash Equivalents | 547.79M |
| Total Debt | 9.78M |
| Net Cash | 610.56M |
| Net Cash Per Share | $9.49 |
| Equity (Book Value) | 655.47M |
| Book Value Per Share | 10.21 |
| Working Capital | 578.91M |
Cash Flow
In the last 12 months, operating cash flow was -$116.64 million and capital expenditures -$1.26 million, giving a free cash flow of -$117.90 million.
| Operating Cash Flow | -116.64M |
| Capital Expenditures | -1.26M |
| Depreciation & Amortization | 1.45M |
| Net Borrowing | n/a |
| Free Cash Flow | -117.90M |
| FCF Per Share | -$1.83 |
Margins
Gross margin is 100.00%, with operating and profit margins of -192.36% and -154.88%.
| Gross Margin | 100.00% |
| Operating Margin | -192.36% |
| Pretax Margin | -155.78% |
| Profit Margin | -154.88% |
| EBITDA Margin | -190.40% |
| EBIT Margin | -192.36% |
| FCF Margin | n/a |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.26% |
| Shareholder Yield | 1.26% |
| Earnings Yield | -1.63% |
| FCF Yield | -1.67% |
Analyst Forecast
The average price target for PTGX is $118.69, which is 8.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $118.69 |
| Price Target Difference | 8.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 89.24% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 60.84 and a Piotroski F-Score of 1.
| Altman Z-Score | 60.84 |
| Piotroski F-Score | 1 |